Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute lymphoid leukemia.

W A Bleyer

    Pediatric Annals
    |April 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Progress in treating childhood acute lymphoblastic leukemia (ALL) has stalled, with cure rates plateauing around 50-60%. New strategies focus on improved staging, diagnostics, and intensive therapies for poor-prognosis cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The management of cancer in the older adolescent.

    European journal of cancer (Oxford, England : 1990)·2003
    Same author

    Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.

    Neuro-oncology·2001
    Same author

    Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

    Leukemia·2001
    Same author

    Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisation.

    Drugs·2000
    Same author

    Epidemiologic impact of children with brain tumors.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·1999
    Same author

    Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.

    Clinical cancer research : an official journal of the American Association for Cancer Research·1999
    Same journal

    Management of Menstrual Disorders in Adolescents of All Abilities.

    Pediatric annals·2026
    Same journal

    The Intersection of Weight Management and Eating Disorders.

    Pediatric annals·2026
    Same journal

    Recognizing and Responding to Complexity in the Medical Care of Adolescents.

    Pediatric annals·2026
    Same journal

    Language Development in Bilingual Children: A Pediatrician's Guide.

    Pediatric annals·2026
    Same journal

    Navigating Identification and Management of Substance Use in Adolescents.

    Pediatric annals·2026
    Same journal

    Risks and Benefits of Social Media on Adolescent Health.

    Pediatric annals·2026
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Hematology
    • Leukemia Research

    Background:

    • Treatment advancements for childhood acute lymphoblastic leukemia (ALL) have plateaued over the last decade.
    • A persistent cure rate barrier between 50% and 60% hinders further progress despite various therapeutic strategies.
    • Conventional intensification of induction, consolidation, or maintenance therapies has largely failed to surmount this treatment obstacle.

    Purpose of the Study:

    • To identify and evaluate novel therapeutic approaches for overcoming the treatment impasse in childhood acute lymphoblastic leukemia (ALL).
    • To explore the impact of improved staging and advanced biological characterization on treatment outcomes.
    • To assess the efficacy of continuous intensive therapy and combined intensive induction consolidation with delayed intensification.

    Related Experiment Videos

    Main Methods:

    • Utilizing improved staging systems for risk stratification.
    • Employing advanced immunodiagnostic methods for precise biological characterization of leukemia.
    • Implementing novel therapeutic strategies, including continuous intensive therapy for high-risk patients.
    • Applying a combination of intensive induction, consolidation, and delayed intensification protocols.

    Main Results:

    • Current therapeutic attempts, including intensified standard therapies, have not significantly improved cure rates beyond the 50-60% plateau.
    • Novel approaches involving enhanced staging and diagnostics are under investigation to better understand and target ALL.
    • Intensive treatment strategies, such as continuous therapy for poor-prognosis cases and combined induction/consolidation/delayed intensification, represent the forefront of current research efforts.

    Conclusions:

    • Significant breakthroughs in childhood acute lymphoblastic leukemia (ALL) treatment require moving beyond conventional therapy intensification.
    • Improved patient stratification through advanced staging and immunodiagnostics is crucial for tailoring effective treatments.
    • Novel intensive therapeutic regimens are being explored to break the existing cure rate barrier in pediatric ALL.